Furthermore, the expression level of IL-6R was lower in the BALF of COVID-19 patients compared to controls with no difference on PBMCs, suggesting that the IL-6/IL6R axis in the epithelial cells of the lungs is the one involved in the immunopathology of the disease [130]. The gene discussed is IL6R; the disease is COVID-19.